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Silmmary 
Serologically distinct forms of H-2K  b are stabilized  by loading cells expressing "empty" class 
I major histocompatibility complex (MHC) molecules with different H-2K  b binding peptides. 
The  H-2K  b epitope  recognized  by  monoclonal antibody  (mAb)  28.8.6  was  stabilized  by 
ovalbumin (OVA) (257-264)  and murine cytomegalovirus (MCMV) pp89 (168-176) peptides, 
but not by vesicular stomatic virus nucleoprotein (VSV NP) (52-59) and influenza NP (Y345- 
360) peptides. The H-2K  b epitope recognized by mAb 34.4.20 was stabilized by VSV NP (52-59) 
peptide but not by OVA (257-264), MCMV pp89 (168-176), or influenza NP (Y345-360) peptides. 
Immunoprecipitation of H-2K  b molecules from normal cells showed that 28.8.6 and 34.4.20 
epitopes were only present on a subset of all conformationally reactive H-2K  b molecules. Using 
alanine-substituted derivatives of the VSV peptide, the 28.8.6 epitope was completely stabilized 
by substitution of the first residue and partially stabilized by substitution of the third or the 
fifth residues in the peptides. These results indicate that distinct conformational MHC epitopes 
are dependent on the specific  peptide that occupies the antigenic peptide binding groove on individual 
MHC molecules. The changes in MHC epitopes observed may also be important in understanding 
the diversity of T  cell receptors used in an immune response and the influence of peptides on 
development of the T  cell repertoire. 
C 
lass I MHC molecules are polymorphic cell surface an- 
tigens with central roles in T  cell-mediated immune 
responses  (for review see reference 1). Stable class I MHC 
expression requires three components, a 45-kD polymorphic 
H chain, a nonpolymorphic L chain (fl2-microglobulin), and 
a peptide bound to the antigenic peptide binding groove in 
the H chain. Currently, evidence indicates that nascent class 
I  MHC  molecules associate  with 32-microglobulin (2-4) 
and antigenic peptide fragments (5-7) in the endoplasmic retic- 
ulum (ER) 1. This association is required for stable cell sur- 
face expression. By studying cells that have global defects in 
class I MHC expression, such as the routine RMA-S and the 
human B cell line .174 (8, 9), investigators have identified 
novel genes involved in antigen processing that regulate cell 
surface expression of class I MHC molecules (10-14). Under 
normal culture conditions these cells do not properly process 
antigen and fail to load their endogenous nascent class I MHC 
molecules with antigenic peptide fragments. Because of this 
1  Abbreviations used in this paper: ER,  endoplasmic reticulum;  MCMV, 
murine cytomegalovirus; NP, nudeoprotein; VSV, vesicular  stomatic virus. 
defect, these cells do not express normal levels of cell surface 
MHC class I molecules. However, "empty" MHC molecules 
are expressed on the surface of RMA-S cells when these cells 
are cultured between 20 and 28~  (15). Although these mol- 
ecules are stable at lower temperatures, they rapidly disas- 
sociate or degrade at 37~  Empty class I MHC molecules 
can be stabilized by the addition of antigenic peptides (15) 
or anti-class  I MHC antibodies (16). 
In the present investigation, we found that serologically 
distinct conformational epitopes on the class I MHC H-2K  b 
molecule were stabilized by loading these cells with different 
H-2K  b binding peptides. Although many determinants rec- 
ognized by mAbs specific for H-2K  b molecules were reac- 
tive regardless of which antigenic peptide bound to H-2K  b, 
two oe2-specific epitopes recognized by mAbs 28.8.6  and 
34.4.20 were dependent on the specific peptide bound to 
H-2K  b. An analysis of the oL2 epitope recognized by mAb 
28.8.6 indicates that specific amino acid residues at positions 
1, 3, and 5 in the H-2K  b binding peptide control stabiliza- 
tion  of that  epitope.  These results indicate that  distinct 
H-2K  b binding antigentic peptides stabilize different confor- 
mational epitopes on H-2K  b.  Changes in conformational 
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tant in TCR recognition of a particular MHC molecule and 
may partially explain the diversity of TCRs used in responding 
to specific MHC  antigens. 
Table  1.  mAb Specificity 
MHC  Domain  Reference 
Antibody  specificity  specificity  no. 
Materials and Methods 
Cells and Culture Conditions.  RMA, RMA-S, E3 K b, and DAP 
K b ceUs were maintained by 1:20 passage three times weekly in 
RPMI-1640  supplemented with  2 mM glutamine,  nonessential 
amino acids, 50 #g/ml of gentamicin, 5  x  10 -s M  2-ME, and 
10%  FCS. 
Cell Transfections.  L cells expressing H-2K  b were previously de- 
scribed (17). EE2H3 cells were transfected by routine calcium phos- 
phate DNA-mediated transfection. For high levels of expression, 
EE2H3 cells were transfected with a cDNA construct encoding 
H-2K  b driven by the human ubiquitin promoter (18). Transfor- 
mants were selected for growth resistance in G418 (1 mg/ml, Gibco 
Laboratories,  Grand Island, NY) from the G418-sensitive parental 
cell line and then screened by flow microfluorometric analysis for 
expression  of H-2KL 
Flow Microfluorometry Analysis.  Approximately 10-20  x  108 
cells were incubated for 60 min at 4~  with 50 #1 of indicated 
purified mAb diluted to 10 #g/ml final concentration or 100-200 
#1 of the specified mAb culture supematants. Cells were washed 
twice in PBS and then incubated for an additional 40 min at 4~ 
in 50 #1 of 1/40 dilution of fluorescent F(ab')z goat anti-mouse 
IgG (Cappel Laboratories, Cochranville, PA). Cells were then washed 
two additional times with PBS before analysis on an Epics Profile 
flow cytometer (Coulter Corp.,  Hialeah, FL). 
raAbs,  mAbs were either used as culture supernatants or fur- 
ther purified by protein A-Sepharose chromatography. See Table 
1 for specificity of different mAbs used to recognize either or1 or 
c~2 serological  epitopes. 
Peptide Loading of Cells.  Cells (RMA, RMA-S, or E3 K b) were 
incubated at either 25~  overnight or at 37~  for peptide-loading 
experiments. Ceils that were maintained at 37~  were either in- 
cubated overnight in the presence of various antigenic peptides 
(100 #M final concentration) or in the absence of any known anti- 
genic peptides.  The following morning cells were harvested and 
processed for flow microftuorometry analysis. Ceils that were main- 
tained overnight at 25~  were incubated with antigenic peptides 
(100/~M) in the morning for 2 h and then incubated for an addi- 
tional 2 h at 37~  CeUs were then harvested and processed for 
flow microfluorometry analysis as described. 
All peptides except murine cytomegalovirus (MCMV) pp89 were 
made by the Johns Hopkins University biopolymer laboratory pep- 
tide synthesis facility. Peptides were made by F-moc chemical syn- 
thesis  and  then purified by preparative HPLC.  Sequences  were 
confirmed by amino  acid  analysis and protein sequencing.  The 
MCMV pp89 peptide was  the generous gift of Dr. David Mar- 
gulies  (National Institutes of Health). 
Imraunoprecipitation.  For labeling of cells,  108 cells were in- 
cubated at 37~  for 40 min in 2 ml methionine-free RPMI-1640 
supplemented with 5% dialyzed FCS. [3sS]Methionine (0.5 mCi) 
was added  for 15 min. Labeling was stopped by the addition of 
2 mM cold methionine at 37~  After incubation for an additional 
2 h, the cells were harvested and 20 ml ice-cold PBS was added. 
The ceUs in PBS were centrifuged at 4~  and the pellet lysed in 
I ml lysis buffer (0.5% NP-40, 20 mM Tris, pH 8.0, 10 mM EDTA, 
pH 8.0, 0.1 M  NaC1,  and 1 mM PMSF).  After 30 rain on ice, 
the nuclei were sedimented at 14,000 rpm for 5 min at 4~  Ly- 
20.8.4  H-2K  b  c~1  (31) 
B8.24.3  H-2K  b  or1  (32,  33) 
28.8.6  H-2K  b  a2  (17,  31) 
34.4.20  H-2K  b  a2  (21,  32) 
5F1  H-2K  b  c~2  (32,  33) 
Y3  H-2Kb  c~1/c~2  (32,  33) 
28.14.8  H-2D  b  or3  (34) 
Summary of the reactivities of different monoclonal anti-MHC antibod- 
ies used in these experiments. The epitope recognized by Y-3 was not 
clearly mapped to either the al or the o~2 domains of H-2K  b. Recently 
this antibody has been more definitively mapped to the a2 domain. 
sates were precleared with 50 #1 of protein A-Sepharose overnight. 
Protein A-sepharose (50 #1) was incubated with various mAbs, 10 
/zg of purified 34.4.20, 28.8.6, or 20.8.4, at 4~  overnight, and 
then free antibody was washed away. Cell lysates were incubated 
with the protein A-sepharose-antibody complex for 1 h at 4~ 
Protein A-sepharose-antibody  beads were then washed at 4~  twice 
with 0.5% NP-40, 20 mM Tris (pH 8.0), 10 mM EDTA, 0.1 M 
NaC1, 0.1% SDS, 1% BSA, once with 10% lysis buffer in 0.5 M 
NaC1, and once in lysis buffer. They were then resuspended in sample 
buffer (50/A) heated to 100~  for 3 min and centrifuged. Samples 
were analyzed by 12% SDS-PAGE. 
Results 
Culturing  RMA-S cells at 25~  overnight is known  to 
enhance expression of empty class I  MHC  molecules (15). 
In our system, flow microfluorometric analysis of cells cul- 
tured at 25~  showed 2.5-3.5-fold increases in expression 
of conformationally intact H-2K  b molecules (Fig. 1). These 
empty H-2K  b molecules were reactive with  the entire  set 
of two  oil-reactive anti-H-2K  b specific mAbs,  20.8.4  and 
B8.24.3,  and  four  oe2-reactive anti-H-2K  b specific mAbs, 
5F1,  28.8.6,  34.4.20,  and Y-3  (data not  shown for Yo3). 
To study epitopes expressed on peptide-stabilized class I 
MHC  molecules,  we  analyzed  the  ability  of four  H-2K  b 
binding  peptides  to  stabilize  empty H-2K  b molecules  ex- 
pressed  on  RMA-S  cells  (Table 2).  Three  of the peptides 
used were previously reported to bind to H-2K  b, vesicular 
stomatic virus nucteoprotein (VSV NP) (52-59), OVA (257- 
264),  and  influenza  NP  (Y345-360).  The fourth  peptide, 
MCMV pp89 (168-176) that was previously described as an 
H-2L  a binding  peptide,  also  bound  to  empty cell  surface 
H-2K  b molecules (Fig. 2). H-2K  b binding was analyzed by 
adding peptides to RMA-S cells that had been cultured over- 
night at 25~  After allowing the peptide to bind and stabi- 
lize the cell surface MHC molecules at 250C, cells were cul- 
tured for an additional 2 h at 37~  to degrade any remaining 
empty H-2K  b molecules. Compared to cells treated with ei- 
ther a control peptide, influenza NP (365-380),  or no pep- 
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Figure  1.  H-2K  b molecules expressed at 25~  are reactive with all 
H-2Kb-specific  mAbs. KMA-S cells were incubated overnight at 25~  in 
a 5% CO2 incubator. The next morning cells were either moved for two 
additional hours of incubation at 37~  (l~) or maintained at 25~  (Ig]) 
until they were all harvested and stained with different mAbs. RMA cells 
(g) were simply maintained overnight at 37~  in a 5% COz incubator 
and harvested immediately before staining with the different mAbs. Flow 
analysis was performed using an Epics fluorometer. Routinely, 5,000 cells 
were analyzed per histogram. Data are presented as mean channel fluores- 
cence on a logarithmic fluorescence  scale. Data presented are from a repre- 
sentative experiment that has been repeated at least three times. 
tide  at  all,  ceils loaded  with  the  H-2K  b binding  peptides, 
VSV NP (52-59) OVA (257-264), influenza NP (Y345-360), 
and MCMV pp89 (168-176), all showed 2.5-4-fold increases 
in cell  surface-expressed H-2K  b conformational  epitopes  as 
recognized  by  the  od-reactive  antibodies  (Fig.  2  A).  The 
otl-reactive mAbs 20.8.4 and B8.24.3 were not differentially 
reactive  with  RMA-S  cells  treated  with  any  of the  four 
H-2K  b binding  peptides.  Stabilization  of the H-2K  b mole- 
cule was peptide specific in that both a peptide that specifically 
bind  to  H-2D  b,  influenza  NP  (365-380)  (Fig.  2  A)  and  a 
randomly chosen 12 amino acid-long peptide (data not shown) 
did not stabilize cell surface expression of H-2K  b. Treatment 
of RMA-S cells with influenza NP (365-380) peptide increased 
H-2D  b  reactivity  twofold  as  seen  by  the  H-2Db-reactive 
mAb  28.14.8  (data  not  shown). 
It  is  interesting  that  not  all  the  or2  epitopes  on  H-2K  b 
were  stabilized  by  each  of  the  H-2K  b  binding  peptides. 
Whereas  the epitope recognized by mAb 28.8.6  was stabi- 
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Figure 2.  Cell surface expression of H-2K  b epitopes on RMA-S cells 
treated with several H-2K  b binding peptides. RMA-S cells were incubated 
overnight in a 5% COz incubator at 25~  The next morning cells were 
pulsed either with peptides (100/~M final concentration) derived from: 
VSV (52-59), (11); OVA (257-264), (D); MCMV pp89 (168-176), (I~); 
or influenza NP (Y345-360), (i); or influenza NP (365-380), (~); for 
1 h at 25~  or without any added peptides (l~). Cells were then incubated 
for an additional 2 h at 37~  At the end of the incubation period, cells 
were harvested and stained with various c~l-reactive mAbs (.4), or c~2- 
reactive mAbs (B). Data are presented as relative mean channel fluores- 
cence, where the reactivity with each of the mAbs has been normalized 
to untreated cells. The mean channel fluorescence  of the various antibodies 
for untreated RMA-S cells in the experiment shown are: 20.8.4, 36.2; 
B8.24.3, 31.3; 28.8.6, 9; 34.4.20, 7; Y3, 24.9; and 5F1, 11. Data presented 
are representative of three experiments. 
lized by OVA (257-264) and MCMV pp89(168-176) peptides, 
H-2K  b  binding  peptides  derived  from  VSV  (52-59)  and 
influenza NP (Y345-360) did not stabilize the 28.8.6 epitope 
(Fig.  2 B).  The effects of the different peptides on the epi- 
tope recognized by mAb 28.8.6 was also seen when RMA-S 
cells were incubated with the H-2K  b binding peptides over- 
night  at 37~  (data  not  shown).  H-2K  b binding  peptides 
derived from OVA (257-264) and MCMV pp89(168-176) in- 
creased reactivity with mAb 28.8.6 3.5-4.5-fold. Mean channel 
fluorescence increased from 9 to 30 for MCMV pp89(168-176) 
treated  and  to 41  for OVA  (257-264)  treated  cells. 
The H-2K  b epitope recognized by the  c~2-reactive mAb 
34.4.20 was also peptide specific. In this case, while the VSV 
(52-59) peptide stabilized the epitope seen by 34.4.20,  pep- 
tides derived from OVA (257-264),  MCMV  (168-176),  and 
Table  2.  MHC Binding Peptides 
Peptide source  Known restriction  element  Sequence  Reference no. 
1.  VSV NP (52-59)  H-2K  b  RGYVYQGL  (35) 
2.  OVA  (257-264)  H-2K  b  SIINFEKL  (25,  36) 
3.  Influenza NP  (Y-345-360)  ('68)  H-2K  b  YSFIRGTKVSPRGKLST  (37) 
4.  MCMVpp89  (168-176)  H-2Ld/H-2K  b  YPHFMPTNL  (38,  and  this  report) 
5.  Influenza NP (365-380)  H-2D  b  IASNENMETMESSTLE  (39) 
1613  Catipovi~  et al. influenza NP (Y345-360) did not stabilize the epitope recog- 
nized by mAb 34.4.20 (Fig. 2 B). The VSV (52-59)  peptide 
increased 34.4.20  reactivity 2.5-fold. 
Other oe2-specific epitopes on H-2K  b were not dependent 
on the specific H-2K  b binding peptide resident in the H-2K  b 
molecule (Fig.  2).  The ol2-specific epitopes recognized by 
antibodies  5F1  and Y3  were stabilized by all four H-2K  b 
binding peptides tested. H-2K  b binding peptides increased 
reactivity with mAb 5F1  4-7-fold and increased reactivity 
with mAb Y3 3-5-fold. To summarize, the VSV (52-59) pep- 
tide stabilized  all H-2K  b epitopes except the epitope recog- 
nized by mAb  28.8.6.  The  OVA  (257-264)  and MCMV 
(168-176) peptides stabilized the epitopes recognized by all 
mAbs except the epitope recognized by 34.4.20. The influenza 
NP (Y345-360)  peptide stabilized all the epitopes except the 
28.8.6  and 34.4.20  epitopes. 
To determine if differential stabilization  of H-2K  b epitopes 
is a general feature of class I-defldent cells or unique to RMA-S 
cells, the effects of peptide binding on class I MHC expres- 
sion in EE2H3 embryonic cells (19) which also express empty 
cell surface class I MHC molecules (20)  were determined. 
For  these experiments,  EE2H3  cells,  which  are  from  an 
H-2K  k mouse, were transfected with an expression vector 
encoding H-2K  b (E3  K b cells).  As  seen with  the RMA-S 
cells, the H-2K  b epitope recognized by mAb 28.8.6 was sta- 
bilized by both OVA (257-264)  and MCMV pp89 (168-176) 
peptides, but not by VSV (52-59) and influenza NP (Y345-360) 
peptides (Fig. 3). Mean channel fluorescence increased 2.5-4.5- 
fold for cells treated with MCMV pp89 (168-176) and OVA 
(257-264)  peptides, respectively.  The epitope recognized by 
34.4.20 was also only stabilized by VSV (52-59) peptide and 
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Figure 3.  Stabilization of cell surface expression of H-2K  b epitopes on 
E-3K  b cells by H-2K  b binding peptides. E-3K  b cells were incubated over- 
night in a 5%  CO2 incubator  at  25~  The next morning cells were 
pulsed either with peptides  (100/~M  final concentration)  derived from: 
VSV  (52-59),  (D);  OVA (257-264),  (~);  MCMV (168-176), ([~);  or 
influenza NP (Y345-360),  ([])  for  1 h at 25~  or without any added 
peptides  ([~). Cells were  then incubated  for an additional  2 h at 37~ 
At the end of the incubation  period,  cells were then harvested and pre- 
pared for staining with various mAbs. Data are presented as relative mean 
channel fluorescence. Mean channel fluorescence of the various antibodies 
for untreated  E-3K  b cells in  the experiment  shown  are: 28.8.6,  16.4; 
34.4.20,  10.5; and  20.8.4,  22.6. 
not by OVA (257-264),  MCMV pp89 (168-176), or influenza 
NP (Y345-360)  peptides (Fig.  3).  Since mAb 28.8.6 cross- 
reacts with H-2D  b which is present on RMA-S cells, anal- 
ysis of the E3 K b cells also confirmed that the increased re- 
activity ofmAb 28.8.6 for peptide-stabilized MHC on RMA-S 
cells was due to binding to  H-2K  b and not to  H-2D b. 
Although  antigenic peptide  loading  of H-2K  b in  both 
I~MA-S  and E-3K  b cells established that serologically dis- 
tinct forms of H-2K  b are peptide specific when empty cell 
surface  H-2K  b  molecules  are  loaded  with  peptides,  we 
wanted to determine if serologically distinct forms of H-2K  b 
exist in normal cells that do not have defective class I MHC 
expression. To assess this possibility, sequential immunoprecipi- 
tations  were  used  to  determine  the  relative  amounts  of 
H-2K  b immunoprecipitated by various anti-H-2Kb-specific 
mAbs.  Because of the crossreactivity of the H-2K  b mAbs 
28.8.6 for H-2D  b and 20.8.4 for Qa2,  H-2K  b was precipi- 
tated from L cells transfected with H-2K  b. These mAbs only 
recognize H-2K  b on the transfected L cells (17), and all have 
comparable avidities  for H-2K  b (B. Catipovic, unpublished 
data),  mAb  28.8.6  precipitated  large  amounts  of H-2K  b 
from labeled H-2K  b transfected L cells (Fig.  4). Two rounds 
of immunoprecipitation depleted the 28.8.6-reactive mate- 
rial from the cell lysates  (Fig.  4 A, lanes A-C). Even after 
three rounds of immunoprecipitation of the 28.8.6-reactive 
material,  significant amounts of 20.8.4-reactive H-2K  b re- 
mained in the lysates (Fig. 4 A, lane D). Whereas significantly 
less material was immunoprecipitated by mAb 34.4.20 (Fig. 
4 B, lanes A-C), immunoprecipitation with 34.4.20 produced 
essentially similar findings. Although two rounds of immu- 
noprecipitation depleted all the 34.4.20-reactive material, sig- 
nificant amounts of 20.8.4-reactive material remained in cell 
lysates  (Fig.  4 B,  lane D).  Thus both anti-H-2-Kb-specific 
mAb 28.8.6 and 34.4.20 precipitated subsets of the total cel- 
lular conformationally intact H-2K  b molecules. 
Figure 4.  H-2K  b epitopes rec- 
ognized  by  mAbs  28.8.6  and 
34.4.20 are present on a subset of 
all H-2K  b molecules.  H-2Kb ex- 
pressing L cells were processed as 
described and immunopredpitated 
with Sepharose coupled to mAb 
28.8.6  (.4,  lanes a--c)  or  mAb 
34.4.20  (B,  lanes a-c).  Lysates 
were initially precleared with one 
round  of  protein  A-Sepharose 
(50/~1). After preclearing, lysates 
were  immunoprecipitated  with 
three  rounds  of the mAb bound 
to  Sepharose  (lanes a-c).  Note 
that almost all the 28.8.6- (A, lane 
c) or 34.4.20- (/3, lane c) reactive 
material was depleted by the third 
round  of immunoprecipitation. 
Lysates  were  then  precipitated 
with mAb 20.8.4 bound to Sepha- 
rose (A and B, laneo). The posi- 
tions  of H  chain  and B2 micro- 
globulin are indicated on the side. 
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peptides on peptide-specific stabilization of H-2K  b epitopes 
was analyzed using alanine substituted VSV (52-59) peptides 
to stabilize empty cell surface H-2K  s molecules. All of the 
alanine-substituted  VSV (52-59) peptides stabilized the epi- 
tope recognized by mAb 20.8.4 (Fig. 5). Only alanine sub- 
stituted at position 8 (VSV [AS]) significantly decreased re- 
activity with 20.8.4.  The inability  of the wild type VSV 
(52-59) peptide to stabilize the H-2K  b epitope recognized by 
28.8.6 was completely reversed by an alanine substitution at 
the first position in the VSV peptide (VSV [A1]) (Fig. 5). 
Relative mean fluorescence  increased more than fourfold. Re- 
activity of cells treated with VSV (A1) was comparable to 
the reactivity  seen with OVA (257-264) treated cells. Ala- 
nine substitution at positions  three and five of the peptide 
also partially stabilized the epitope recognized by mAb 28.8.6. 
In three independent experiments, reactivity with 28.8.6 in- 
creased 1.5-1.75-fold when H-2K  b was stabilized with VSV 
(A3), and increased 1.9-2.5-fold when H-2K  b was stabilized 
with VSV (A5).  None of the other alanine substitutions 
significantly increased reactivity  with mAb 28.8.6. 
The epitope recognized by mAb 34.4.20, which ordinarily 
is stabilized by treatment with wild type VSV (52-59) pep- 
tide, was not very sensitive to the alanine substitutions  of 
the VSV peptide.  Only partial  loss of the 34.4.20  epitope 
was seen in cells treated  with VSV (A5). 
Discussion 
This and a companion paper (20a) are the first demonstra- 
tions that distinct conformational MHC epitopes are depen- 
dent on the antigenic peptide that resides  in the peptide binding 
groove of the MHC molecule. The experiments presented 
in this manuscript show that when empty, H-2K  b molecules 
are loaded with peptides, H-2K  b epitopes associated  with the 
Figure 5.  Effects of alanine substituted  VSV peptides  on stabilization 
of H-2K  b epitopes. E-3K  b cells were incubated  overnight in a 5% CO2 
incubator  at 25~  The next morning cells were pulsed either with wild 
type VSV, VSV-substituted peptides, OVA (257-64) peptide (all at 100/~M 
final concentration),  or without any added peptides.  Cells were then in- 
cubated for an additional 2 h at 37~  At the end of the incubation period, 
cells were then harvested and prepared  for staining  with various mAbs. 
Data are presented  as relative mean channel  fluorescence. Mean channel 
fluorescence of the various antibodies  for untreated  RMA-S cells in the 
experiment  shown are: 28.8.6,  17.8; 34.4.20,  12; and  20.8.4,  31. 
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0r  hdix identified by mAbs 28.8.6  and 34.4.20  are stabi- 
lized by certain peptides, but not by all H-2K  b binding pep- 
tides. Specifically,  the epitope recognized by 28.8.6 was not 
stabilized by peptides derived from VSV (52-59) or influenza 
NP (Y345-360), and the epitope recognized by 34.4.20 was 
not stabilized by OVA (257-264), MCMV pp89 (168-176), 
or influenza NP (Y345-360) peptides. The influence of pep- 
tides on conformational MHC epitopes is not only seen with 
empty dass I molecules loaded exogenously with peptides, 
but may also occur in MHC molecules expressed on normal 
cells. Evidence for this comes from our finding that the epi- 
topes recognized by mAbs 28.8.6 and 34.4.20 are only present 
on subsets of all conformationally intact H-2K  b molecules 
in cells that express normal levels of dass I MHC molecules. 
It has previously been shown that MHC  determinants 
expressed on erythrocytes and blastocysts are serologically 
distinct from the same  MHC determinants expressed on lym- 
phocytes (21). In retrospect, this may reflect a different spec- 
trum of peptide-specific MHC  determinants expressed by 
blastocysts and by erythrocytes  than those found on lympho- 
cytes that were used to make the mAbs. It is interesting that 
it was also the cr  epitopes that were missing from the MHC 
molecules expressed by the erythrocytes. 
A likely explanation of our data is that dass I MHC mole- 
cule conformations are peptide dependent. Empty MHC mol- 
ecules, which are reactive with all mAbs tested, are confor- 
mationaUy unstable. Presumably, these empty molecules exist 
in a temperature-dependent floppy configuration. In this case, 
MHC molecules can explore conformational states and can 
be trapped in a specific conformational state by mAbs (16). 
The recent three-dimensional x-ray crystallography structure 
of H-2K  b cocrystallized with two different peptides  shows 
that  small but  significant differences in the H-2K  b class I 
MHC molecule were seen when crystallized with the two 
different peptides (22). Our results indicate that when anti- 
genic peptides bind to either empty cell surface MHC mole- 
cules or newly formed MHC molecules in the ER, the pep- 
tide  may also fix  the  MHC  molecule  in  one  of several 
serologically distinct configurations. Our strongest support 
for this hypothesis is from the effects of alanine substitution 
at position 5 in the VSV peptide on stabilization of the epi- 
tope recognized by 28.8.6. Both positions 3 and 5 are anchor 
residues that interact directly with amino acid residues in the 
MHC molecule. Position 5 in the VSV peptide is a buried 
residue whose side chain faces down and is not exposed to 
solvent (22). It is unlikely that position 5 in the VSV peptide 
can directly interact with the surface of the MHC molecule. 
Thus the influence of position 5 and in the VSV peptide on 
28.8.6 reactivity is probably not secondary to steric interac- 
tions between that position in the peptide and the mAb. These 
changes may be indicative of conformational changes in the 
MHC molecule. 
Although we favor the hypothesis that the differences  seen 
in the serological reactivity  with different H-2K  b binding 
peptides indicates a conformational change in the MHC mol- 
ecule, there are other interpretations  of the data. An alterna- 
tive hypothesis is that individual  antigenic peptides, when 
bound to MHC molecules, can obscure specific mAb reac- tivities.  The strongest argument for this idea is from the 
finding that all the serological epitopes are expressed on con- 
formationally unstable empty H-2K  b molecules. Thus one 
might argue that when the antigenic peptide derived from 
VSV NP (52-59) bound to the H-2K  b molecule, it obscured 
the epitope recognized by 28.8.6 but not the epitope seen 
by 34.4.20.  The three-dimensional x-ray crystallographic data 
indicate that the nonamer peptide is embedded in the anti- 
genic peptide binding groove and that the peptide backbone 
is thought to lie deep in the antigenic peptide binding groove 
(23, 24). Thus it seems unlikely that nonamer peptides could 
entirely mask serological epitopes that have been mapped to 
polymorphisms on the surface of the MHC helical regions 
(23).  However, peptide side chains could still interact with 
the surface of the MHC molecule (24)  and interfere with 
access to mAb binding sites. The effect of an alanine for argi- 
nine substitution at position 1 of the VSV (52-59)  peptide 
seen in analysis  of the H-2K  b epitope recognized by mAb 
28.8.6 could be due to steric inhibition. This H-2K  b epitope 
is known to map to the terminal portion of the c~ helix of 
the oe2 domain (17). Alteration of amino acid positions 167 
or 173 of H-2K  b completely abolishes the 28.8.6 epitope on 
H-2K  b  (J.  P.  Schneck,  unpublished  data).  Based  on  the 
crystal structure of antigenic peptides bound to MHC mole- 
cules, we know that the NH2-terminal portion of antigenic 
peptides lie in close proximity to the beginning of the oe he- 
lical region of or1 and the terminal portion of the ot helical 
region of or2. Thus  arginine in position  1 could directly 
influence the relevant area of the MHC molecule and may 
sterically interfere with binding of mAb 28.8.6. Ultimately, 
a structural analysis of MHC molecules loaded with either 
one of two different peptides that have been shown to stabi- 
lize serologically distinct forms of that MHC molecule will 
help determine if the MHC is fixed in two different confor- 
mational states,  or if peptides obscure different serological 
epitopes. 
Another hypothesis we entertained was that these mAb 
binding sites were combinational binding sites that were part 
MHC and part peptide. This seems unlikely since all the mAbs 
react with the empty H-2K  b molecule. Even if the empty 
MHC molecules are only functionally empty, it is still un- 
likely that the antibody binding sites are combinational. Were 
this the case, it is surprising that reactivity with mAb 28.8.6 
could be stabilized by incubation with the two different pep- 
tides derived from either OVA (257-264)  or from MCMV 
pp89.  These peptides have no apparent homology to each 
other.  Even the H-2K  b peptide binding motif (25)  is not 
easily identifiable in the MCMV peptide. Since peptides de- 
rived from VSV, MCMV, and OVA do not occur naturally 
in the mouse, it also seems unlikely that we would have stum- 
bled on three peptides that were crossreactive with actual en- 
dogenously occurring peptides that could potentially form 
part of the binding cleft for the mAbs. If these antibodies 
actually have combinational binding sites, they are qualita- 
tively different than other mAbs that  have combinational 
binding sites (26-28). These previously described mAbs with 
combinational binding sites are specific for a single peptide 
in the context of an MHC molecule. The unique aspect of 
the antibodies reported in this study is that they are not specific 
for one peptide, but recognize a class of peptides associated 
with H-2KL 
Independent of the mechanism by which peptides alter sero- 
logical MHC epitopes, presumably, these changes are also 
important for TCR recognition. Whereas antigenic peptide 
binding to MHC molecules clearly confers a specific confor- 
mation that antigen-specific TCRs recognize, our data shows 
that a prominent effect of antigenic peptide binding is loss 
of certain serological conformational MHC epitopes. Recent 
work analyzing TCR interaction with the antigenic pep- 
tide-MHC complex has focused on the direct interaction be- 
tween the third hypervariable region of the c~ and 3  chains 
of the TCRs and the antigenic peptide bound to the MHC 
molecule (29, 30).  However, this does not explain why T 
cells often use many different ot and 3  chains when inter- 
acting with a specific MHC restriction element. Different 
TCR c~ and 3 chains not only have changes in the third hyper- 
variable domain, but also differ in the first two hypervariable 
regions. The loss of conformational epitopes seen with pep- 
tide binding may also influence contact regions between the 
first two hypervariable regions on the ot and B chains of the 
TCR and the MHC portion of the antigen-MHC complex. 
Thus a TCR may use different ot and ~ chains to accommo- 
date specific antigenic peptide-MHC complexes that have ei- 
ther stabilized the MHC in a specific conformation or limited 
access to certain area of the MHC molecule. Peptide-dependent 
alterations in the MHC molecule may also influence the way 
endogenous peptides in the thymus shape the development 
of the T  cell repertoire during thymic maturation. 
The experimental system described here uses cells that ex- 
press empty MHC molecules to probe the influence of specific 
peptides on MHC structure. This system has allowed us to 
analyze the effects of uniform loading of MHC molecules 
with specific peptides on the conformational states of MHC 
molecules. These findings indicate that peptide binding to 
MHC molecules may affect the T cell repertoire by topographi- 
cally altering the areas available for interaction between MHC 
molecules and TCRs. 
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